Max Life Insurance demonstrated a resilient performance amid a challenging macro environment with 21 per cent annual premium equivalent (APE) growth
The board of directors declared payment of a third interim dividend (special) for the financial year 2020-21 at Rs 100 per share
The management believes the company is in multi-year technology transformation period of accelerated consumer adoption of mobile and connected devices globally
M&M expects the industry to log around 20 per cent YoY volume growth in the tractor segment for FY21E
The stock will turn ex-date for bonus issue on Wednesday, February 3
The optimism despite higher borrowing and a wider fiscal deficit, analysts say, was on account of the positive measures to revive the Covid-19 hit economy
The private lender is looking to grow its loan book by 15-18 per cent YoY for the next two financial years under its fifth planning cycle
The Finance Minister announced an allocation of Rs 1.18 trillion for the Ministry of Road Transport and Highways
Net interest income of the company grew 57 per cent YoY to Rs 573 crore
The company said it is not providing quantitative guidance for fiscal 2021 as in the near-term there are still reasons to remain cautious
In Q3FY21, the company reported a net profit of Rs 5.50 crore against a net loss of Rs 7.2 crore in year-ago quarter
During Q3FY21, L&T's standalone adjusted net profit came in at Rs 1,705 crore against Rs 1,261 crore in Q3FY20
Stay tuned for Latest LIVE news
Apollo Hospitals said it will use the funds raised to acquire a 50 per cent stake in a joint venture, seek inorganic growth opportunities, as well as, look to pare down debt in its balance sheet
The Indian paint industry is valued at approximately Rs 54,500 crore and is expected to grow to Rs 97,100 crore by 2024, according to the estimates of Indsec Research
The company's net profit more than doubled to Rs 1,584 crore in the quarter ended December 31, 2020
Sebi gave a go-ahead to Future Group's scheme of arrangement and sale of assets to Reliance
The stock is trading close to its 52-week high level of Rs 138, scaled on January 29, 2020
Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US
The management has indicated that the automotive segment continues to face headwinds especially in passenger vehicles and commercial vehicle segment and going ahead sees recovery to be very gradual